Impact of cryopreservation and subsequent embryo transfer on the outcome of in vitro fertilization in patients at high risk for ovarian hyperstimulation syndrome

Author： Wiener-Megnazi Z.   Lahav-Baratz S.   Rothschild E.   Abramovici H.   Dirnfeld M.  

Publisher： Elsevier

ISSN： 0015-0282

Source： Fertility and Sterility, Vol.78, Iss.1, 2002-07, pp. : 201-203

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cycle-specific and cumulative fecundity in patients with endometriosis who are undergoing controlled ovarian hyperstimulation-intrauterine insemination or in vitro fertilization-embryo transfer

By Dmowski W.P.   Pry M.   Ding J.   Rana N.  

Fertility and Sterility, Vol. 78, Iss. 4, 2002-10 ,pp. : 750-756

Elsevier

Access to resources Recommend Favorite

Impact of intramural leiomyomata in patients with a normal endometrial cavity on in vitro fertilization-embryo transfer cycle outcome

By Surrey E.S.   Lietz A.K.   Schoolcraft W.B.  

Fertility and Sterility, Vol. 75, Iss. 2, 2001-02 ,pp. : 405-410

Elsevier

Access to resources Recommend Favorite

Difficult embryo transfer has a negative impact on the outcome of in vitro fertilization

By Spandorfer S.D.   Goldstein J.   Navarro J.   Veeck L.   Davis O.K.   Rosenwaks Z.  

Fertility and Sterility, Vol. 79, Iss. 3, 2003-03 ,pp. : 654-655

Elsevier

Access to resources Recommend Favorite

Influence of severe endometriosis on gene expression of vascular endothelial growth factor and interleukin-6 in granulosa cells from patients undergoing controlled ovarian hyperstimulation for in vitro fertilization-embryo transfer

By Yamashita Y.   Ueda M.   Takehara M.   Yamashita H.   Suzuki Y.   Hung Y.-C.   Terai Y.   Ueki M.  

Fertility and Sterility, Vol. 78, Iss. 4, 2002-10 ,pp. : 865-871

Elsevier

Access to resources Recommend Favorite

Is coasting effective for preventing ovarian hyperstimulation syndrome in patients receiving a gonadotropin-releasing hormone antagonist during an in vitro fertilization cycle?

By Delvigne A.   Carlier C.   Rozenberg S.  

Fertility and Sterility, Vol. 76, Iss. 4, 2001-10 ,pp. : 844-846

Elsevier

Access to resources Recommend Favorite